Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial.
作者信息
Enomoto M, Tamori A, Kawada N, Jomura H, Nishiguchi S, Saibara T, Onishi S, Mochida S, Fujiwara K
出版信息
Gut. 2006 Jan;55(1):139-40. doi: 10.1136/gut.2005.081935.
Abstract
摘要
相似文献
1
Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial.
Gut. 2006 Jan;55(1):139-40. doi: 10.1136/gut.2005.081935.
2
High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study.
J Gastroenterol. 2002;37(9):732-6. doi: 10.1007/s005350200119.
3
Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C?
J Am Geriatr Soc. 2006 Mar;54(3):549-50. doi: 10.1111/j.1532-5415.2006.00643_4.x.
4
Pilot study of interferon-alpha-ribavirin-interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1.
J Viral Hepat. 2006 Feb;13(2):139-44. doi: 10.1111/j.1365-2893.2005.00694.x.
5
A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
Hepatology. 2001 Aug;34(2):377-84. doi: 10.1053/jhep.2001.26086.
6
Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.
J Acquir Immune Defic Syndr. 1999 Nov 1;22(3):308-9. doi: 10.1097/00126334-199911010-00014.
7
Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C.
J Gastroenterol Hepatol. 2006 Jul;21(7):1177-83. doi: 10.1111/j.1440-1746.2006.04311.x.
8
9
Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1.
J Infect Dis. 2003 Apr 1;187(7):1071-4. doi: 10.1086/368217. Epub 2003 Mar 7.
10
Virological response in post-partum treated chronic hepatitis C women with pegylated interferon-alpha plus ribavirin. A case-control study.
J Clin Virol. 2004 Dec;31(4):314-5. doi: 10.1016/j.jcv.2004.07.002.
引用本文的文献
1
Successful Treatment of Hepatitis B Virus Reactivation With a Combination of Entecavir and Short-Term Administration of Interferon-β Twice per Day.
Cureus. 2024 Jul 6;16(7):e63978. doi: 10.7759/cureus.63978. eCollection 2024 Jul.
2
Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status.
Liver Cancer. 2018 Sep;7(3):261-276. doi: 10.1159/000486902. Epub 2018 Mar 13.
3
Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia.
Clin J Gastroenterol. 2014 Aug;7(4):355-60. doi: 10.1007/s12328-014-0500-8. Epub 2014 Jun 6.
本文引用的文献
1
Monitoring of viral levels during therapy of hepatitis C.
Hepatology. 2002 Nov;36(5 Suppl 1):S145-51. doi: 10.1053/jhep.2002.36798.
2
The science, economics, and effectiveness of combination therapy for hepatitis C.
Gut. 2000 Aug;47(2):159-61. doi: 10.1136/gut.47.2.159.
3
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15623-8. doi: 10.1073/pnas.95.26.15623.
4
Differential use of the betaL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNalpha2 and IFNbeta.
J Biol Chem. 1998 Feb 6;273(6):3144-7. doi: 10.1074/jbc.273.6.3144.
5
A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C.
Gastroenterology. 1993 Aug;105(2):507-12. doi: 10.1016/0016-5085(93)90727-t.
Zotero 插件